Index S&P 500
P/E 61.68
EPS (ttm) 2.72
Insider Own 0.11%
Shs Outstand 1.77B
Perf Week 2.16%
Market Cap 297.12B
Forward P/E 13.81
EPS next Y 12.15
Insider Trans -19.17%
Shs Float 1.77B
Perf Month -6.01%
Income 4.82B
PEG 9.73
EPS next Q 2.26
Inst Own 71.78%
Short Float 0.77%
Perf Quarter 2.18%
Sales 54.32B
P/S 5.47
EPS this Y 0.12%
Inst Trans 0.10%
Short Ratio 2.41
Perf Half Y 15.94%
Book/sh 5.87
P/B 28.60
EPS next Y 9.23%
ROA 3.52%
Short Interest 13.54M
Perf Year 2.27%
Cash/sh 7.24
P/C 23.18
EPS next 5Y 6.34%
ROE 34.90%
52W Range 130.96 - 182.89
Perf YTD 8.28%
Dividend Est. 6.23 (3.71%)
P/FCF 13.49
EPS past 5Y -5.77%
ROI 7.61%
52W High -8.25%
Beta 0.58
Dividend TTM 6.06 (3.61%)
Quick Ratio 0.76
Sales past 5Y 11.76%
Gross Margin 70.40%
52W Low 28.13%
ATR (14) 3.20
Dividend Ex-Date Apr 12, 2024
Current Ratio 0.87
EPS Y/Y TTM -59.03%
Oper. Margin 37.04%
RSI (14) 44.01
Volatility 1.64% 1.84%
Employees 50000
Debt/Eq 5.80
Sales Y/Y TTM -6.44%
Profit Margin 8.87%
Recom 2.00
Target Price 184.49
Option/Short Yes / Yes
LT Debt/Eq 5.11
EPS Q/Q -67.09%
Payout 220.33%
Rel Volume 0.71
Prev Close 169.54
Sales Surprise 1.97%
EPS Surprise -0.11%
Sales Q/Q -5.42%
Earnings Apr 26 BMO
Avg Volume 5.62M
Price 167.80
SMA20 -1.70%
SMA50 -4.12%
SMA200 7.31%
Trades
Volume 3,974,142
Change -1.03%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-29-24 Upgrade
William Blair
Mkt Perform → Outperform
Dec-18-23 Downgrade
HSBC Securities
Buy → Hold
Dec-11-23 Upgrade
Goldman
Neutral → Buy
Nov-09-23 Initiated
Deutsche Bank
Hold
$150
Oct-30-23 Upgrade
Barclays
Equal Weight → Overweight
$160 → $170
Oct-20-23 Resumed
UBS
Neutral
$157 → $150
Sep-29-23 Initiated
Raymond James
Outperform
$177
Jul-25-23 Initiated
William Blair
Mkt Perform
Jul-14-23 Initiated
HSBC Securities
Buy
$167
Apr-05-23 Downgrade
Argus
Buy → Hold
Mar-01-23 Initiated
Guggenheim
Buy
$172
Feb-22-23 Downgrade
Wolfe Research
Outperform → Peer Perform
Feb-10-23 Upgrade
SVB Securities
Underperform → Market Perform
$135 → $153
Nov-18-22 Initiated
Credit Suisse
Outperform
$170
Nov-08-22 Downgrade
Societe Generale
Buy → Hold
Aug-01-22 Downgrade
Atlantic Equities
Overweight → Neutral
$178 → $162
May-23-22 Initiated
SVB Leerink
Underperform
$140
May-06-22 Downgrade
Daiwa Securities
Outperform → Neutral
$150
Apr-06-22 Resumed
Morgan Stanley
Overweight
$192
Feb-28-22 Downgrade
UBS
Buy → Neutral
$129 → $147
Show Previous Ratings
Apr-23-24 03:09PM
12:38PM
12:14PM
09:15AM
08:00AM
12:56PM
Loading…
Apr-22-24 12:56PM
09:47AM
Apr-21-24 07:00AM
Apr-19-24 04:11PM
(Investor's Business Daily)
10:00AM
Apr-18-24 03:44PM
12:18PM
(The Wall Street Journal)
08:31AM
06:30AM
Apr-17-24 05:45PM
10:21AM
Loading…
Apr-16-24 10:21AM
10:01AM
09:00AM
08:00AM
03:06AM
03:02AM
Apr-15-24 07:57AM
07:43AM
Apr-14-24 01:23AM
Apr-13-24 12:18PM
Apr-12-24 04:19PM
07:30AM
Apr-11-24 05:45PM
07:02AM
Apr-10-24 10:53AM
08:00AM
Loading…
Apr-09-24 08:00AM
07:13AM
04:21AM
Apr-08-24 05:50PM
09:19AM
Apr-06-24 06:49AM
Apr-05-24 05:45PM
09:00AM
08:00AM
06:39AM
Apr-04-24 06:52PM
08:00AM
Apr-03-24 08:48AM
08:30AM
Apr-02-24 12:41PM
10:28AM
08:00AM
03:36AM
Apr-01-24 05:45PM
07:50AM
04:30AM
Mar-31-24 11:52AM
Mar-30-24 05:19AM
Mar-29-24 12:16PM
Mar-28-24 01:38PM
Mar-27-24 10:00AM
Mar-26-24 10:03AM
08:36AM
06:18AM
04:56AM
Mar-25-24 05:45PM
01:27PM
12:58PM
12:40PM
11:45AM
11:00AM
09:25AM
09:00AM
08:39AM
08:37AM
08:31AM
08:05AM
Mar-24-24 03:54PM
11:04AM
Mar-22-24 07:00PM
03:10PM
03:02PM
02:35PM
Mar-21-24 10:25AM
10:00AM
08:00AM
Mar-19-24 05:45PM
08:32AM
08:00AM
08:00AM
Mar-17-24 08:15AM
Mar-14-24 09:38AM
08:18AM
Mar-13-24 05:45PM
08:17AM
06:30AM
Mar-12-24 01:20PM
09:00AM
08:33AM
08:09AM
Mar-11-24 06:21PM
04:25PM
(Investor's Business Daily)
09:28AM
Mar-10-24 10:18AM
10:00AM
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER Mar 20 '24 Sale 176.30 21,082 3,716,757 55,903 Mar 22 05:00 PM Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER Mar 18 '24 Option Exercise 61.36 26,110 1,602,110 119,890 Mar 20 05:00 PM Stewart Jeffrey Ryan EVP, CHIEF COMMERCIAL OFFICER Mar 18 '24 Sale 178.79 58,949 10,539,508 60,941 Mar 20 05:00 PM RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER Mar 01 '24 Option Exercise 61.36 45,700 2,804,152 89,517 Mar 05 05:30 PM RICHMOND TIMOTHY J. EVP, CHIEF HR OFFICER Mar 01 '24 Sale 177.27 75,680 13,415,503 13,837 Mar 05 05:30 PM Michael Robert A. PRES & CHIEF OPERATING OFFICER Feb 29 '24 Option Exercise 58.30 21,560 1,257,012 167,524 Mar 01 05:50 PM Michael Robert A. PRES & CHIEF OPERATING OFFICER Feb 29 '24 Sale 176.45 68,879 12,153,957 98,645 Mar 01 05:50 PM Siatis Perry C EVP, GC AND SECRETARY Feb 29 '24 Sale 177.39 9,891 1,754,555 10,397 Mar 01 05:50 PM Buckbee Kevin K SVP, CONTROLLER Feb 29 '24 Sale 176.65 5,144 908,688 6,983 Mar 01 05:50 PM GONZALEZ RICHARD A CHAIRMAN OF THE BOARD AND CEO Feb 28 '24 Sale 177.27 138,616 24,572,458 519,099 Mar 01 05:50 PM Siatis Perry C EVP, GC AND SECRETARY Feb 23 '24 Option Exercise 137.36 13,753 1,889,115 41,926 Feb 27 05:10 PM Reents Scott T EVP, CHIEF FINANCIAL OFFICER Feb 23 '24 Option Exercise 61.36 14,140 867,630 41,205 Mar 01 05:50 PM Reents Scott T EVP, CHIEF FINANCIAL OFFICER Feb 23 '24 Sale 177.44 14,140 2,509,002 27,065 Mar 01 05:50 PM Siatis Perry C EVP, GC AND SECRETARY Feb 23 '24 Sale 177.51 13,753 2,441,295 28,173 Feb 27 05:10 PM SALEKI-GERHARDT AZITA EVP, CHIEF OPERATIONS OFFICER Feb 21 '24 Option Exercise 58.88 52,870 3,112,986 296,814 Feb 23 05:00 PM SALEKI-GERHARDT AZITA EVP, CHIEF OPERATIONS OFFICER Feb 21 '24 Sale 173.71 52,870 9,184,048 243,944 Feb 23 05:00 PM Donoghoe Nicholas EVP, CHIEF BUS/STRAT OFFICER Dec 26 '23 Sale 154.72 2,912 450,545 55,903 Dec 28 05:00 PM GONZALEZ RICHARD A CHAIRMAN OF THE BOARD AND CEO Aug 01 '23 Sale 148.58 60,000 8,914,800 565,294 Aug 02 05:07 PM GONZALEZ RICHARD A CHAIRMAN OF THE BOARD AND CEO Jul 31 '23 Sale 149.15 18,500 2,759,275 625,294 Aug 02 05:07 PM
Index S&P 500
P/E 35.18
EPS (ttm) 3.05
Insider Own 0.19%
Shs Outstand 243.91M
Perf Week 3.73%
Market Cap 26.18B
Forward P/E 28.66
EPS next Y 3.75
Insider Trans -63.77%
Shs Float 243.44M
Perf Month 4.23%
Income 755.60M
PEG 3.63
EPS next Q 0.87
Inst Own 88.69%
Short Float 2.61%
Perf Quarter 10.56%
Sales 5.87B
P/S 4.46
EPS this Y 8.80%
Inst Trans -0.89%
Short Ratio 4.91
Perf Half Y 17.90%
Book/sh 15.86
P/B 6.77
EPS next Y 8.61%
ROA 8.93%
Short Interest 6.35M
Perf Year 16.86%
Cash/sh 1.41
P/C 76.01
EPS next 5Y 9.70%
ROE 20.57%
52W Range 82.25 - 107.42
Perf YTD 13.53%
Dividend Est. 1.14 (1.06%)
P/FCF 32.44
EPS past 5Y 6.12%
ROI 12.12%
52W High -0.07%
Beta 0.51
Dividend TTM 1.10 (1.03%)
Quick Ratio 0.64
Sales past 5Y 7.24%
Gross Margin 41.99%
52W Low 30.52%
ATR (14) 1.65
Dividend Ex-Date Feb 14, 2024
Current Ratio 1.08
EPS Y/Y TTM 80.67%
Oper. Margin 18.02%
RSI (14) 69.19
Volatility 1.92% 1.45%
Employees 5550
Debt/Eq 0.68
Sales Y/Y TTM 9.16%
Profit Margin 12.88%
Recom 2.64
Target Price 98.12
Option/Short Yes / Yes
LT Debt/Eq 0.62
EPS Q/Q 192.04%
Payout 35.72%
Rel Volume 0.71
Prev Close 106.71
Sales Surprise 1.05%
EPS Surprise 0.65%
Sales Q/Q 6.41%
Earnings May 02 BMO
Avg Volume 1.29M
Price 107.35
SMA20 3.95%
SMA50 5.01%
SMA200 11.51%
Trades
Volume 912,837
Change 0.60%
Date
Action
Analyst
Rating Change
Price Target Change
Mar-01-24 Resumed
Goldman
Buy
$110
Feb-23-24 Upgrade
Argus
Hold → Buy
$115
Dec-15-23 Upgrade
BofA Securities
Underperform → Neutral
$85 → $100
Dec-13-23 Downgrade
Citigroup
Neutral → Sell
$90
Nov-13-23 Initiated
Jefferies
Hold
$99
Oct-23-23 Upgrade
Raymond James
Underperform → Mkt Perform
Sep-22-23 Initiated
HSBC Securities
Hold
$102
Aug-28-23 Upgrade
Truist
Hold → Buy
$95 → $105
Feb-17-23 Initiated
Citigroup
Neutral
$85
Feb-13-23 Downgrade
Argus
Buy → Hold
Feb-07-23 Reiterated
Oppenheimer
Outperform
$93
Feb-06-23 Upgrade
Atlantic Equities
Underweight → Neutral
$80
Jan-17-23 Upgrade
Morgan Stanley
Equal-Weight → Overweight
$82 → $91
Jan-17-23 Upgrade
Credit Suisse
Neutral → Outperform
$85 → $95
Nov-07-22 Upgrade
Argus
Hold → Buy
$78
Oct-18-22 Initiated
Evercore ISI
In-line
Oct-17-22 Upgrade
Morgan Stanley
Underweight → Equal-Weight
$82
Oct-05-22 Upgrade
Deutsche Bank
Hold → Buy
$90 → $85
Sep-14-22 Resumed
BofA Securities
Underperform
$75
Sep-08-22 Downgrade
Truist
Buy → Hold
Show Previous Ratings
Apr-22-24 04:20PM
(Investor's Business Daily)
Apr-21-24 07:22AM
Apr-17-24 03:35PM
(Investor's Business Daily)
Apr-16-24 12:10PM
Apr-15-24 10:17AM
07:43AM
Loading…
07:43AM
Apr-11-24 11:45AM
Apr-04-24 04:43AM
Apr-02-24 04:28AM
Mar-29-24 07:45AM
Mar-28-24 05:09AM
Mar-24-24 07:30PM
Mar-18-24 12:49PM
08:54AM
Mar-15-24 05:07PM
07:00AM
Loading…
Mar-13-24 07:00AM
Mar-12-24 08:40AM
Mar-04-24 01:00AM
Feb-28-24 04:41AM
Feb-27-24 12:00PM
Feb-16-24 12:12AM
Feb-15-24 03:21PM
Feb-12-24 01:02PM
09:40AM
Feb-06-24 01:02PM
02:01AM
02:01AM
Feb-05-24 02:01AM
Feb-03-24 09:02AM
Feb-02-24 02:56PM
01:00PM
Loading…
01:00PM
09:30AM
08:05AM
07:56AM
07:41AM
07:11AM
(Associated Press Finance)
07:08AM
06:55AM
Feb-01-24 02:00AM
Jan-30-24 11:20PM
09:03PM
10:29AM
09:15AM
Jan-26-24 10:34AM
10:00AM
Jan-25-24 03:49AM
Jan-24-24 08:45AM
Jan-19-24 12:10PM
Jan-16-24 04:35PM
Dec-20-23 07:42AM
Dec-14-23 04:51PM
Dec-07-23 09:08AM
07:24AM
Dec-01-23 04:40PM
Nov-22-23 12:12PM
Nov-16-23 07:07AM
Nov-14-23 05:07AM
Nov-07-23 12:43PM
Nov-05-23 02:23PM
Nov-04-23 01:34AM
(Thomson Reuters StreetEvents)
Nov-03-23 05:12PM
04:25PM
12:32PM
11:33AM
11:30AM
10:32AM
08:49AM
08:45AM
07:42AM
07:18AM
(The Wall Street Journal)
07:02AM
(Associated Press Finance)
06:55AM
Nov-02-23 10:31AM
07:22AM
Nov-01-23 12:29PM
11:33AM
08:34AM
Oct-31-23 10:27AM
07:43AM
Oct-30-23 11:08AM
11:06AM
09:44AM
09:39AM
09:08AM
09:06AM
08:54AM
07:58AM
Oct-27-23 10:00AM
09:56AM
09:23AM
08:31AM
Oct-26-23 09:50AM
08:17AM
06:49AM
Oct-25-23 09:57AM
09:55AM
04:51AM
Oct-20-23 12:13PM
12:00PM
10:24AM
Church & Dwight Co., Inc. engages in the development, manufacture, and marketing of household, personal care, and specialty products. It operates through the following segments: Consumer Domestic, Consumer International, Specialty Products, and Corporate. The Consumer Domestic segment offers household products, such as laundry detergents, fabric softener sheets, cat litter, and household cleaning products, and personal care products including antiperspirants, oral care products, depilatories, reproductive health products, oral analgesics, nasal saline moisturizers, and dietary supplements. The Consumer International segment sells personal care products, household and over-the-counter products in Canada, France, Australia, China, the United Kingdom, Mexico, and Brazil. The Specialty Products segment consists of sales to businesses which participated in different product areas, namely animal productivity, specialty chemicals, and specialty cleaners. The Corporate segment includes equity in earnings of affiliates from Armand and ArmaKleen in 2021, 2020 and 2019. The company was founded by Dwight John and Austin Church in 1846 and is headquartered in Ewing, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bruno Barry A. EVP, Chf Mktng Offcr Pres CD Mar 13 '24 Option Exercise 49.62 9,926 492,528 14,245 Mar 14 09:24 AM Bruno Barry A. EVP, Chf Mktng Offcr Pres CD Mar 13 '24 Sale 104.55 9,926 1,037,805 4,319 Mar 14 09:24 AM FARRELL MATTHEW President and CEO Mar 11 '24 Option Exercise 41.76 275,000 11,482,625 387,719 Mar 12 11:30 AM IRWIN BRADLEY C Director Mar 11 '24 Option Exercise 53.75 5,590 300,462 42,759 Mar 12 11:13 AM Read Michael EVP, International Mar 11 '24 Option Exercise 51.67 4,500 232,515 4,500 Mar 12 11:00 AM FARRELL MATTHEW President and CEO Mar 11 '24 Sale 103.83 275,000 28,552,535 112,719 Mar 12 11:30 AM IRWIN BRADLEY C Director Mar 11 '24 Sale 104.12 5,590 582,014 37,169 Mar 12 11:13 AM Read Michael EVP, International Mar 11 '24 Sale 105.00 4,500 472,500 0 Mar 12 11:00 AM Dierker Richard A EVP, CFO & Head of Business Op Mar 07 '24 Option Exercise 73.87 24,380 1,800,951 32,014 Mar 08 10:52 AM Dierker Richard A EVP, CFO & Head of Business Op Mar 07 '24 Sale 103.61 24,380 2,526,061 7,634 Mar 08 10:52 AM Saligram Ravichandra Krishnamu Director Mar 06 '24 Option Exercise 34.81 15,504 539,694 49,297 Mar 07 10:22 AM Buchert Brian D EVP of Strategy, M&A, and BP Mar 06 '24 Option Exercise 38.33 12,120 464,527 6,120 Mar 07 09:51 AM Saligram Ravichandra Krishnamu Director Mar 06 '24 Sale 102.25 15,504 1,585,315 33,793 Mar 07 10:22 AM Buchert Brian D EVP of Strategy, M&A, and BP Mar 06 '24 Sale 102.84 12,120 1,246,369 0 Mar 07 09:51 AM DE MAYNADIER PATRICK D EVP, Gen. Counsel & Secretary Mar 05 '24 Option Exercise 53.75 48,537 2,608,875 58,862 Mar 06 11:09 AM DE MAYNADIER PATRICK D EVP, Gen. Counsel & Secretary Mar 05 '24 Sale 102.00 48,537 4,950,796 10,325 Mar 06 11:09 AM Read Michael EVP, International Mar 04 '24 Option Exercise 51.67 9,000 465,030 9,000 Mar 05 01:29 PM Read Michael EVP, International Mar 04 '24 Sale 100.95 9,000 908,577 0 Mar 05 01:29 PM Bruno Barry A. EVP, Chf Mktng Offcr, Pres CD Feb 27 '24 Option Exercise 41.91 10,993 460,772 15,312 Feb 29 04:10 PM Bruno Barry A. EVP, Chf Mktng Offcr, Pres CD Feb 27 '24 Sale 99.66 10,993 1,095,519 4,319 Feb 29 04:10 PM Price Penry W Director Feb 09 '24 Option Exercise 34.81 7,752 269,847 33,444 Feb 12 11:45 AM Price Penry W Director Feb 09 '24 Sale 98.29 7,752 761,952 25,692 Feb 12 11:45 AM Hemsey Rene EVP, Chief HR Officer Feb 07 '24 Option Exercise 34.82 9,280 323,137 11,653 Feb 08 10:42 AM Hemsey Rene EVP, Chief HR Officer Feb 07 '24 Sale 100.22 9,280 930,025 6,373 Feb 08 10:42 AM FARRELL MATTHEW President and CEO Feb 06 '24 Option Exercise 41.76 275,000 11,482,625 387,719 Feb 07 02:28 PM Linares Carlos G. EVP Chief Tech&Global New Prod Feb 06 '24 Option Exercise 53.47 79,603 4,256,616 42,813 Feb 07 03:20 PM FARRELL MATTHEW President and CEO Feb 06 '24 Sale 100.28 275,000 27,578,182 112,719 Feb 07 02:28 PM Linares Carlos G. EVP Chief Tech&Global New Prod Feb 06 '24 Sale 100.59 79,603 8,007,656 2,730 Feb 07 03:20 PM WINKLEBLACK ARTHUR B Director Feb 05 '24 Option Exercise 49.62 12,960 643,075 20,089 Feb 06 10:31 AM IRWIN BRADLEY C Director Feb 05 '24 Option Exercise 51.88 10,960 568,615 42,367 Feb 06 10:52 AM WINKLEBLACK ARTHUR B Director Feb 05 '24 Sale 99.30 12,960 1,286,902 7,129 Feb 06 10:31 AM IRWIN BRADLEY C Director Feb 05 '24 Sale 99.35 10,960 1,088,864 36,367 Feb 06 10:52 AM Read Michael EVP, International Nov 30 '23 Option Exercise 51.67 4,500 232,515 4,500 Dec 01 10:11 AM Read Michael EVP, International Nov 30 '23 Sale 96.00 4,500 432,000 0 Dec 01 10:11 AM FARRELL MATTHEW President and CEO Aug 30 '23 Option Exercise 41.91 132,881 5,569,707 245,325 Aug 31 09:55 AM FARRELL MATTHEW President and CEO Aug 30 '23 Sale 96.00 132,881 12,756,576 112,444 Aug 31 09:55 AM FARRELL MATTHEW President and CEO Aug 14 '23 Option Exercise 41.91 27,181 1,139,292 139,625 Aug 15 01:39 PM FARRELL MATTHEW President and CEO Aug 14 '23 Sale 96.03 27,181 2,610,325 112,444 Aug 15 01:39 PM Dierker Richard A EVP, CFO & Head of Business Op Aug 10 '23 Option Exercise 73.87 90,000 6,648,300 97,544 Aug 14 01:00 PM FARRELL MATTHEW President and CEO Aug 10 '23 Option Exercise 41.91 1,280 53,651 113,724 Aug 14 01:17 PM Dierker Richard A EVP, CFO & Head of Business Op Aug 10 '23 Sale 95.80 90,000 8,622,369 7,544 Aug 14 01:00 PM FARRELL MATTHEW President and CEO Aug 10 '23 Sale 97.07 1,280 124,247 112,444 Aug 14 01:17 PM FARRELL MATTHEW President and CEO Aug 03 '23 Option Exercise 41.91 4,591 192,432 117,035 Aug 04 01:57 PM FARRELL MATTHEW President and CEO Aug 03 '23 Sale 97.07 4,591 445,666 112,444 Aug 04 01:57 PM FARRELL MATTHEW President and CEO Aug 02 '23 Option Exercise 37.82 7,006 264,959 116,483 Aug 03 11:08 AM FARRELL MATTHEW President and CEO Aug 02 '23 Sale 97.15 7,006 680,664 112,444 Aug 03 11:08 AM Hemsey Rene EVP, Chief HR Officer May 09 '23 Option Exercise 30.96 7,460 230,962 13,776 May 10 08:53 AM Hemsey Rene EVP, Chief HR Officer May 09 '23 Sale 96.56 7,460 720,334 6,316 May 10 08:53 AM SHEARER ROBERT K Director May 02 '23 Option Exercise 49.62 12,960 643,075 42,068 May 03 09:48 AM SHEARER ROBERT K Director May 02 '23 Option Exercise 53.75 11,590 622,962 40,698 May 03 09:56 AM Bruno Barry A. EVP, Chf Mktng Offcr Pres CD May 02 '23 Option Exercise 34.81 6,440 224,176 10,742 May 03 09:04 AM Bruno Barry A. EVP, Chf Mktng Offcr Pres CD May 02 '23 Option Exercise 34.35 4,000 137,400 8,302 May 03 08:55 AM SHEARER ROBERT K Director May 02 '23 Sale 96.23 12,960 1,247,110 29,108 May 03 09:48 AM SHEARER ROBERT K Director May 02 '23 Sale 96.23 11,590 1,115,278 29,108 May 03 09:56 AM Bruno Barry A. EVP, Chf Mktng Offcr Pres CD May 02 '23 Sale 96.27 6,440 619,954 4,302 May 03 09:04 AM Bruno Barry A. EVP, Chf Mktng Offcr Pres CD May 02 '23 Sale 96.27 4,000 385,065 4,302 May 03 08:55 AM Dierker Richard A EVP, CFO & Head of Business Op May 01 '23 Option Exercise 77.33 88,630 6,853,758 96,174 May 02 11:51 AM FARRELL MATTHEW President and CEO May 01 '23 Option Exercise 34.81 138,081 4,806,600 250,525 May 02 12:17 PM FARRELL MATTHEW President and CEO May 01 '23 Sale 97.02 138,081 13,396,246 112,444 May 02 12:17 PM Dierker Richard A EVP, CFO & Head of Business Op May 01 '23 Sale 96.70 88,630 8,570,645 7,544 May 02 11:51 AM DE MAYNADIER PATRICK D EVP, Gen. Counsel & Secretary Apr 28 '23 Option Exercise 49.62 45,642 2,264,770 55,967 May 01 02:07 PM IRWIN BRADLEY C Director Apr 28 '23 Option Exercise 41.91 7,660 321,069 50,829 May 01 02:44 PM DE MAYNADIER PATRICK D EVP, Gen. Counsel & Secretary Apr 28 '23 Sale 97.06 45,642 4,430,186 10,325 May 01 02:07 PM IRWIN BRADLEY C Director Apr 28 '23 Sale 97.48 8,000 779,807 35,169 May 01 02:55 PM IRWIN BRADLEY C Director Apr 28 '23 Sale 97.48 7,660 746,665 43,169 May 01 02:44 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite